Table 8. Diagnostic accuracies of APRI and FIB-4 for predicting liver fibrosis (Moderate to severe necroinflammation score 9–18, N = 540).
Index | AUROCcutoff | Bootstrap AUROCcutoff | cutoff | sensitivitycutoff | specificitycutoff | PPVcutoff | NPVcutoff | Sensitivity + Specificity-1 |
---|---|---|---|---|---|---|---|---|
To predict fibrosis ≥2 | ||||||||
APRI | 0.65 (0.61–0.70) | 0.65(0.61–0.70) | 2.2 | 61.5% | 69.3% | 83.9% | 40.9% | 30.9% |
FIB-4 | 0.68 (0.64–0.72) | 0.68 (0.64–0.73) | 3.0 | 67.4% | 68.8% | 84.8% | 44.8% | 36.1% |
To predict fibrosis ≥3 | ||||||||
APRI | 0.65(0.61–0.69) | 0.68 (0.64–0.72) | 1.4 | 84.3% | 45.0% | 70.8% | 64.4% | 36.5% |
FIB-4 | 0.71 (0.67–0.75) | 0.70 (0.66–0.74) | 2.9 | 76.1% | 65.1% | 77.5% | 63.3% | 41.2% |
To predict fibrosis = 4 | ||||||||
APRI | 0.68 (0.64–0.72) | 0.68 (0.64–0.72) | 2.2 | 76.1% | 59.4% | 50.0% | 82.3% | 35.4% |
FIB-4 | 0.70(0.66–0.74) | 0.70 (0.66–0.74) | 5.0 | 54.3% | 84.9% | 65.8% | 77.7% | 39.7% |
APRI, aspartate aminotransferase (AST)- to-platelet ratio index; FIB-4, fibrosis index based on the four factors; AUROC, area under receiver operating characteristic